Literature DB >> 9054242

Association between toenail selenium and risk of acute myocardial infarction in European men. The EURAMIC Study. European Antioxidant Myocardial Infarction and Breast Cancer.

A F Kardinaal1, F J Kok, L Kohlmeier, J M Martin-Moreno, J Ringstad, J Gómez-Aracena, V P Mazaev, M Thamm, B C Martin, A Aro, J D Kark, M Delgado-Rodriguez, R A Riemersma, P van 't Veer, J K Huttunen.   

Abstract

The association between selenium status and risk of acute myocardial infarction was examined in a multicenter case-control study in 10 centers from Europe and Israel in 1991-1992. Selenium in toenails was assessed for 683 nonfatal male cases with first acute myocardial infarction and 729 controls less than 70 years of age. Median toenail selenium content was 0.553 microgram/g for cases and 0.590 microgram/g for controls. After adjustment for age, center, and smoking, the odds ratio for myocardial infarction in the highest quintile of selenium as compared with the lowest was 0.63 (95 percent confidence interval 0.37-1.07, p for trend = 0.08). The observed inverse trend was somewhat stronger when the authors adjusted for vitamin E status (p = 0.05). Analysis stratified for smoking habits showed an inverse association in former smokers (odds ratio for the 75th-25th percentile contrast = 0.63 (95 percent confidence interval 0.43-0.94)), but not in current smokers (odds ratio = 0.97 (0.71-1.32)) or in those who had never smoked (odds ratio = 1.55 (0.87-2.76)). Analysis stratified by center showed a significant inverse association between selenium levels and risk of myocardial infarction for Germany (Berlin) only (75th to 25th percentile odds ratio = 0.62 (95 percent confidence interval 0.42-0.91)), which was the center with the lowest selenium levels. It appears that the increased risk of acute myocardial infarction at low levels of selenium intake is largely explained by cigarette smoking; selenium status does not appear to be an important determinant of risk of myocardial infarction at the levels observed in a large part of Europe.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054242     DOI: 10.1093/oxfordjournals.aje.a009115

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.

Authors:  Michael A O'Rorke; Marie M Cantwell; Christian C Abnet; And John D Brockman; Liam J Murray
Journal:  Int J Cancer       Date:  2012-03-06       Impact factor: 7.396

2.  Selenium and coronary heart disease: a meta-analysis.

Authors:  Gemma Flores-Mateo; Ana Navas-Acien; Roberto Pastor-Barriuso; Eliseo Guallar
Journal:  Am J Clin Nutr       Date:  2006-10       Impact factor: 7.045

3.  Factors associated with longitudinal plasma selenium decline in the elderly: the EVA study.

Authors:  Josiane Arnaud; Tasnime N Akbaraly; N Tasmine Akbaraly; Isabelle Hininger; Anne-Marie Roussel; Claudine Berr
Journal:  J Nutr Biochem       Date:  2006-12-04       Impact factor: 6.048

4.  Distribution of toenail selenium levels in young adult Caucasians and African Americans in the United States: the CARDIA Trace Element Study.

Authors:  Pengcheng Xun; Deborah Bujnowski; Kiang Liu; J Steve Morris; Zhongqin Guo; Ka He
Journal:  Environ Res       Date:  2011-02-11       Impact factor: 6.498

5.  Longitudinal association between toenail selenium levels and measures of subclinical atherosclerosis: the CARDIA trace element study.

Authors:  Pengcheng Xun; Kiang Liu; J Steven Morris; Martha L Daviglus; Ka He
Journal:  Atherosclerosis       Date:  2010-01-25       Impact factor: 5.162

Review 6.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 7.  Regulation and function of selenoproteins in human disease.

Authors:  Frederick P Bellinger; Arjun V Raman; Mariclair A Reeves; Marla J Berry
Journal:  Biochem J       Date:  2009-07-29       Impact factor: 3.857

8.  Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study.

Authors:  Renate Schnabel; Edith Lubos; Claudia M Messow; Christoph R Sinning; Tanja Zeller; Philipp S Wild; Dirk Peetz; Diane E Handy; Thomas Munzel; Joseph Loscalzo; Karl J Lackner; Stefan Blankenberg
Journal:  Am Heart J       Date:  2008-12       Impact factor: 4.749

9.  A case--control study of selenium in nails and prostate cancer risk in British men.

Authors:  N E Allen; J S Morris; R A Ngwenyama; T J Key
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

10.  Increased hair selenium concentration in hyperlipidemic patients.

Authors:  Péter Fülöp; Ildikó Seres; Zoltán Jenei; Imre Juhász; György Paragh
Journal:  J Cell Mol Med       Date:  2013-02-13       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.